- CIIX
subsidiary working to expand customer base with new hemp-based CBD
products in 2020
- CEO
focused on profits in 2020; plans to create strategic B2B, B2C divisions
- CBD
Biotech unaffected by changing CBD-product regulations due to company’s
focus on hemp-based CBD cosmetics
ChineseInvestors.com Inc. (OTCQB: CIIX) is a financial
news media and content platform that provides information to the global
Chinese-speaking community. After realizing the multitude of opportunities in
the growing cannabis sector, especially concerning China’s nascent CBD market,
CIIX has worked to cultivate an attractive lineup of products through its
subsidiary CBD Biotech. While cannabis is still highly illegal in China,
hemp-based CBD can be legally added to cosmetics. The team at CIIX recognizes
the massive potential of the untapped Chinese CBD market.
CIIX has a user base of more than 100,000 people and has
been around since 1999. Company CEO Warren Wang recently made an appearance on
MoneyTV, during which he spoke about the company’s plans for 2020, many of
which involve CBD Biotech. “The key is profit,” Wang stated in the
interview (http://ibn.fm/Ub6cJ).
“Secondly [we will] expand our market. Thirdly, we are going to divide the
company divisions into B2B and B2C.”
Wang outlined plans to advertise via social media platforms
such as TikTok in order to increase CIIX’s brand recognition and deepen its
market penetration. In China, Wang explains, several different social media
platforms have massive followings, as “young generations will use a lot of
social media to know the products, know the commentary, and they will buy the
products from Ecommerce platforms.”
Wang noted that China’s changing CBD laws can create
volatility for CBD companies. However, those laws don’t apply to hemp-based CBD
cosmetics, which are fully legal in China, Japan and the United States. Because
CIIX is only involved in CBD cosmetics, the company remains unaffected by the
changing regulations and is able to operate in a stable environment.
In 2020, CIIX will be launching new CBD cosmetic products,
including an anti-aging product formulated to combat wrinkles. By targeting the
Chinese-speaking community, CIIX has few competitors and plenty of room to
grow. The company maintains its attention on the investment of both the
distribution and the research and development of new CBD products.
CIIX is a diverse company driven by educational services and
the sales of cosmetics, hemp wine and CBD. CIIX offers its audience of
Chinese-speaking investors real-time market commentary, analysis and
educational-related services in both traditional and simplified Chinese
character language sets.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates
relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
